← Leaderboards
Victor M. Karpyak
Mayo Clinic Rochester
$3,624,336
Attributed
$7,248,671
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,248,671 · 6
By mechanism
U01$4,386,503 · 2
R01$2,027,416 · 2
R21$834,752 · 2
Top collaborators
- Joanna M Biernacka12 shared
- Vijay H Shah2 shared
- Stacey J Winham2 shared
- Graziano Pinna1 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Joanna M Biernacka$6,043,821
- Amy C Degnim$9,208,153
- Douglas A. Simonetto$942,636
- Ming-Fen Ho$2,322,565
- Ryan Thomas Hurt$1,152,158
Others in their field
Top investigators on “Alcohol Use Disorder”
- Susan F Tapert · Veterans Medical Research Fdn/San Diego$36,426,161
- Edward V Nunes · Columbia University Health Sciences$35,834,967
- Roger D. Weiss · Mc Lean Hospital (Belmont, Ma)$34,906,102
- Joel Gelernter · Washington University$32,645,588
- Lloyd D Johnston · University Of Michigan At Ann Arbor$32,190,173
- Lisa A Marsch · University Of Vermont &St Agric College$31,793,295
Research focus
Alcohol Use DisorderTreatment ResponseSamplingGenesGenome-WideSelection For TreatmentsTreatment OutcomePathway InteractionsResponseGenome Wide Association StudyPharmaceutical PreparationsAcamprosateHeavy DrinkingPharmacogenomicsGeneticGenetic VariationGenetic MarkersPhenotypeGlutamatesBiological MarkersCandidate Disease GenePlacebosProblem DrinkerTreatment Strategy
Grant awards (17)
Neurosteroids and Alcohol Use Disorder$734,283
R01 · FY2025 · AA · contact PI
Genomics of Alcohol Withdrawal and Treatment Response to Benzodiazepines$374,995
R01 · FY2025 · AA · contact PI
Integrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD) â Mayo Clinic$355,080
U01 · FY2025 · AA
Genomics of Alcohol Withdrawal and Treatment Response to Benzodiazepines$369,593
R01 · FY2024 · AA · contact PI
Integrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD) â Mayo Clinic$355,080
U01 · FY2024 · AA
Genomics of Alcohol Withdrawal and Treatment Response to Benzodiazepines$548,545
R01 · FY2023 · AA · contact PI
Pharmacogenomics of Acamprosate Treatment Outcome (Supplement)$155,616
U01 · FY2023 · AA · contact PI
PHARMACOGENOMICS OF ACAMPROSATE TREATMENT OUTCOME$416,055
U01 · FY2022 · AA · contact PI
PHARMACOGENOMICS OF ACAMPROSATE TREATMENT OUTCOME$676,116
U01 · FY2021 · AA · contact PI
PHARMACOGENOMICS OF ACAMPROSATE TREATMENT OUTCOME$719,820
U01 · FY2020 · AA · contact PI
IMPACT OF SEX-RELATED HORMONE LEVELS AND GENETIC VARIATION ON ALCOHOL USE DISORDERS AND RELATED PHENOTYPES IN MALES AND FEMALES$228,563
R21 · FY2020 · AA
PHARMACOGENOMICS OF ACAMPROSATE TREATMENT OUTCOME$754,148
U01 · FY2019 · AA · contact PI
PHARMACOGENOMICS OF ACAMPROSATE TREATMENT OUTCOME$190,678
U01 · FY2019 · AA · contact PI
IMPACT OF SEX-RELATED HORMONE LEVELS AND GENETIC VARIATION ON ALCOHOL USE DISORDERS AND RELATED PHENOTYPES IN MALES AND FEMALES$188,813
R21 · FY2019 · AA
PHARMACOGENOMICS OF ACAMPROSATE TREATMENT OUTCOME$763,910
U01 · FY2018 · AA · contact PI
Pharmacogenomics of Treatment Outcomes in Alcohol Use Disorders$149,063
R21 · FY2017 · AA
Pharmacogenomics of Treatment Outcomes in Alcohol Use Disorders$268,313
R21 · FY2016 · AA